Search

Board Moves September 27, 2018

Elaine Darby has advised AusCann Group Holdings of her intention to step down as managing director as the company transitions from a startup, focused on licensing and product development, to a pharmaceutical production and sales business. Ms  Darby will continue in her role to ensure an orderly transition of leadership responsibilities. Paul MacLeman has been appointed executive director and will lead the executive search process for a new chief executive. Dr  MacLeman has over 25 years of board and executive experience across the life sciences, agricultural and not-for-profit sectors.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Total Shareholder Return as at 28/09/18

1 year TSR5 year TSR
65thAusCann Group Holdings116%61%
567thPhylogica-23%17%
705thNeurotech International-46%0%
809thTech Mpire-73%-18%
739 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

09/08/18
$15k Issued
10/05/17
$0 Other
10/05/17
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

209th↓Tech Mpire$73k
210th↓Neurotech International$67k
211th↓AusCann Group Holdings$54k
212th↓Activistic$49k
213th↓Phylogica$48k
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer